About small company with long ambitions.

Verdares Kern is an Australian deep-tech company building process intelligence platforms for problems that matter — pharmaceutical manufacturing decarbonisation and antimicrobial resistance research.

Pharmaceutical manufacturing is one of the most energy- and resource-intensive industries serving human health.

Pressure to decarbonise

Regulators, investors and public expectations are raising the pressure to cut emissions — without compromising the reliable supply of medicines.

Why conventional fixes aren't enough

Most efforts begin with cleaner energy and more efficient equipment. Both matter, but upgrades can take time and significant investment — while still leaving avoidable losses inside the process untouched.

Two ventures. One umbrella company.

There is a faster lever, and it has been hiding inside historian databases the entire time. Get more product from the same energy. Reduce process variability. Lower the carbon embodied in every dose of medicine produced. Verdares Kern was founded to build the analytical systems that make this lever usable.

Industrial decarbonisation through process intelligence

Process intelligence platform for pharmaceutical batch manufacturing. Deterministic, evidence-gated analytics identify the controllable parameters driving yield loss, facility-specific, fully reproducible, audit-trail-ready, and designed for shadow-mode deployment alongside your existing systems.

Data type

Real production + simulation

IP

2 provisional patents

Status

Validated · first pilots 2027

Validation

3

case studies

Computational mass spectrometry for bacterial cell wall biology

Mass spectrometry analytics for peptidoglycan structure determination, enhanced by machine learning — supporting antimicrobial resistance research and novel antibiotic discovery in collaboration with international research partners.

Domain

AMR · Bacterial cell wall

Method

Mass spec + ML

Status

Validation stage

Partner

UQ

University of Queensland
  • 01

    Get more product from the same energy.

  • 02

    Reduce process variability.

  • 03

    Lower the carbon embodied in every dose of medicine produced.

We help pharmaceutical manufacturers waste less of what they make

The plant’s record

Temperatures, pressures, feed rates, timings — every batch, already in the historian.

Verdares

Physics-informed screening of every controllable setting against measured outcomes.

The drivers, ranked

The handful of settings actually driving the loss — graded by evidence.

No new equipment. No new process. The plant you already have, run on what it already knows.

The people behind Verdares Kern

Analytical Precision

Computational Depth

Biological Insight

Key institutional affiliations

  • Helmholtz Munich
  • University of Tübingen
  • Leibniz Institute for Immunotherapy
  • Griffith University
  • Faculty of Chemistry, University of Belgrade
  • University of Queensland
  • CSIRO
Dr Žarko Barjaktarović

Dr Žarko Barjaktarović

Founder & CEO

Jovan Popović

Jovan Popović

Co-Founder & CTO

For pharmaceutical manufacturers, research collaborators, and government programs.

We work with partners supporting industrial decarbonisation and AMR research. Initial conversations are direct and confidential.